Vital Signs - Developing Microfluidics Diagnostics; Way to Medical Revolution

Vital Signs - Developing Microfluidics Diagnostics; Way to Medical Revolution

 

RELEASE DATE
05-Mar-2007
REGION
North America
Research Code: 9561-00-29-00-00
SKU: HC00473-NA-MR_03945
AvailableYesPDF Download
$1,500.00
In stock
SKU
HC00473-NA-MR_03945
$1,500.00
DownloadLink
ENQUIRE NOW

Description

This issue of Vital Signs, released on March 5, 2007, provides a strategic overview of the potential impact of microfluidics in the healthcare and life sciences areas. Additionally, an emerging company profile is provided for Cepheid, a molecular diagnostics company that develops and markets fully-integrated genetic analysis systems for the industrial, clinical, and bio-defense markets. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of February 19 - February 23, 2007.

Table of Contents

This week's issue:

Related Research
This issue of Vital Signs, released on March 5, 2007, provides a strategic overview of the potential impact of microfluidics in the healthcare and life sciences areas. Additionally, an emerging company profile is provided for Cepheid, a molecular diagnostics company that develops and markets fully-integrated genetic analysis systems for the industrial, clinical, and bio-defense markets. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of February 19 - February 23, 2007.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number 9561-00-29-00-00
Is Prebook No